-
Je něco špatně v tomto záznamu ?
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report
M. Maurer-Granofszky, A. Schumich, B. Buldini, G. Gaipa, J. Kappelmayer, E. Mejstrikova, L. Karawajew, J. Rossi, AÇ. Suzan, E. Agriello, T. Anastasiou-Grenzelia, V. Barcala, G. Barna, D. Batinić, JP. Bourquin, M. Brüggemann, K. Bukowska-Strakova,...
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
825749 "CLOSER"
European Union's H2020 Research and Innovation Program
26.01.2019 / 42/772
Polish Ministry of Health program
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
34885257
DOI
10.3390/cancers13236148
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Monitoring of minimal residual disease (MRD) by flow cytometry (FCM) is a powerful prognostic tool for predicting outcomes in acute lymphoblastic leukemia (ALL). To apply FCM-MRD in large, collaborative trials, dedicated laboratory staff must be educated to concordantly high levels of expertise and their performance quality should be continuously monitored. We sought to install a unique and comprehensive training and quality control (QC) program involving a large number of reference laboratories within the international Berlin-Frankfurt-Münster (I-BFM) consortium, in order to complement the standardization of the methodology with an educational component and persistent quality control measures. Our QC and quality assurance (QA) program is based on four major cornerstones: (i) a twinning maturation program, (ii) obligatory participation in external QA programs (spiked sample send around, United Kingdom National External Quality Assessment Service (UK NEQAS)), (iii) regular participation in list-mode-data (LMD) file ring trials (FCM data file send arounds), and (iv) surveys of independent data derived from trial results. We demonstrate that the training of laboratories using experienced twinning partners, along with continuous educational feedback significantly improves the performance of laboratories in detecting and quantifying MRD in pediatric ALL patients. Overall, our extensive education and quality control program improved inter-laboratory concordance rates of FCM-MRD assessments and ultimately led to a very high conformity of risk estimates in independent patient cohorts.
Bioquimica Inmunologia Hospital de Ninos Rocardo Gutierrez Buenos Aires C1425EFD Argentina
Cellular Immunology Laboratory Hospital de Pediatria Dr Juan P Garrahan Buenos Aires C1245 Argentina
Children's Cancer Research Institute Medical University of Vienna 1090 Vienna Austria
Clinic for Hematology and Tumor Immunology HELIOS Klinikum Berlin Buch 13125 Berlin Germany
Clinica Pediatrica University degli Studi di Milano Biococca Fondazione MBBM 20900 Monza Italy
Department of Cytopathology Institute of Oncology 1000 Ljubljana Slovenia
Department of Hematology University Hospital Schleswig Holstein 24105 Kiel Germany
Department of Immunology and Histocompatibility Agia Sophia Children's Hospital 115 27 Athens Greece
Department of Laboratory Medicine University of Debrecen 4032 Debrecen Hungary
Department of Microbiology and Immunology Medical University of Silesia 40 055 Katowice Poland
Department of Pediatric Oncology and Hematology Charité Berlin 10117 Berlin Germany
Department of Pediatric Oncology Hippokration General Hospital 546 42 Thessaloniki Greece
Faculty of Medicine University of Ljubljana 1000 Ljubljana Slovenia
Flow Cytometry Laboratory FUNDALEU Buenos Aires C1114 Argentina
Georgios Gennimatas General Hospital of Athens 115 27 Athens Greece
Hematology Lab Sheba Medical Center Ramat Gan 52621 Israel
Hospital de Clinica Jose de San Martin Buenos Aires C1120 Argentina
Hospital Guillermo Rawson San Juan J5400 Argentina
Hospital Nacional de Clínicas Universidad Nacional de Córdoba Cordoba X5000HUA Argentina
IICT Labs Rosario S2000 Argentina
Laboratorio CEBAC SRL Posadas N3300 Argentina
Laboratory Flow Cytometry Citomlab Buenos Aires C1406AWK Argentina
LEB Laboratorio Servicio de Hematologia Hospital Penna Bahia Blanca B8000 Argentina
National Institute of Children's Diseases 831 01 Bratislava Slovakia
P and A Kyriakou Children's Hospital of Athens 115 27 Athens Greece
PAPSI Laboratorio Mendoza Rosario S2000 Argentina
Pediatric Hematology and Oncology Hospital Sant Joan de Deu 08950 Barcelona Spain
Servicio de Bioquimica Hospital Posadas Buenos Aires B1684 Argentina
The Children's Hospital at Westmead Sydney NSW 2145 Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22001106
- 003
- CZ-PrNML
- 005
- 20220112153502.0
- 007
- ta
- 008
- 220107s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers13236148 $2 doi
- 035 __
- $a (PubMed)34885257
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Maurer-Granofszky, Margarita $u Children's Cancer Research Institute, Medical University of Vienna, 1090 Vienna, Austria
- 245 13
- $a An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report / $c M. Maurer-Granofszky, A. Schumich, B. Buldini, G. Gaipa, J. Kappelmayer, E. Mejstrikova, L. Karawajew, J. Rossi, AÇ. Suzan, E. Agriello, T. Anastasiou-Grenzelia, V. Barcala, G. Barna, D. Batinić, JP. Bourquin, M. Brüggemann, K. Bukowska-Strakova, H. Burnusuzov, D. Carelli, G. Deniz, K. Dubravčić, T. Feuerstein, MI. Gaillard, A. Galeano, H. Giordano, A. Gonzalez, S. Groeneveld-Krentz, Z. Hevessy, O. Hrusak, MB. Iarossi, P. Jáksó, V. Kloboves Prevodnik, S. Kohlscheen, E. Kreminska, O. Maglia, C. Malusardi, N. Marinov, BM. Martin, C. Möller, S. Nikulshin, J. Palazzi, G. Paterakis, A. Popov, R. Ratei, C. Rodríguez, EO. Sajaroff, S. Sala, G. Samardzija, M. Sartor, P. Scarparo, Ł. Sędek, B. Slavkovic, L. Solari, P. Svec, T. Szczepanski, A. Taparkou, M. Torrebadell, M. Tzanoudaki, E. Varotto, H. Vernitsky, A. Attarbaschi, M. Schrappe, V. Conter, A. Biondi, M. Felice, M. Campbell, C. Kiss, G. Basso, MN. Dworzak, . On Behalf Of I-Bfm-Flow-Network
- 520 9_
- $a Monitoring of minimal residual disease (MRD) by flow cytometry (FCM) is a powerful prognostic tool for predicting outcomes in acute lymphoblastic leukemia (ALL). To apply FCM-MRD in large, collaborative trials, dedicated laboratory staff must be educated to concordantly high levels of expertise and their performance quality should be continuously monitored. We sought to install a unique and comprehensive training and quality control (QC) program involving a large number of reference laboratories within the international Berlin-Frankfurt-Münster (I-BFM) consortium, in order to complement the standardization of the methodology with an educational component and persistent quality control measures. Our QC and quality assurance (QA) program is based on four major cornerstones: (i) a twinning maturation program, (ii) obligatory participation in external QA programs (spiked sample send around, United Kingdom National External Quality Assessment Service (UK NEQAS)), (iii) regular participation in list-mode-data (LMD) file ring trials (FCM data file send arounds), and (iv) surveys of independent data derived from trial results. We demonstrate that the training of laboratories using experienced twinning partners, along with continuous educational feedback significantly improves the performance of laboratories in detecting and quantifying MRD in pediatric ALL patients. Overall, our extensive education and quality control program improved inter-laboratory concordance rates of FCM-MRD assessments and ultimately led to a very high conformity of risk estimates in independent patient cohorts.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Schumich, Angela $u Children's Cancer Research Institute, Medical University of Vienna, 1090 Vienna, Austria
- 700 1_
- $a Buldini, Barbara $u Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, University of Padova, 35122 Padova, Italy
- 700 1_
- $a Gaipa, Giuseppe $u M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, 20900 Monza, Italy
- 700 1_
- $a Kappelmayer, Janos $u Department of Laboratory Medicine, University of Debrecen, 4032 Debrecen, Hungary
- 700 1_
- $a Mejstrikova, Ester $u Department of Paediatric Haematology and Oncology, University Hospital Motol, 150 06 Prague, Czech Republic
- 700 1_
- $a Karawajew, Leonid $u Department of Pediatric Oncology and Hematology, Charité Berlin, 10117 Berlin, Germany
- 700 1_
- $a Rossi, Jorge $u Cellular Immunology Laboratory, Hospital de Pediatria "Dr. Juan P. Garrahan", Buenos Aires C1245, Argentina
- 700 1_
- $a Suzan, Adın Çınar $u Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, 34452 Istanbul, Turkey
- 700 1_
- $a Agriello, Evangelina $u LEB Laboratorio, Servicio de Hematologia Hospital Penna, Bahia Blanca B8000, Argentina
- 700 1_
- $a Anastasiou-Grenzelia, Theodora $u P.&A. Kyriakou Children's Hospital of Athens, 115 27 Athens, Greece
- 700 1_
- $a Barcala, Virna $u Laboratory-Flow Cytometry, Citomlab, Buenos Aires C1406AWK, Argentina
- 700 1_
- $a Barna, Gábor $u 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary
- 700 1_
- $a Batinić, Drago $u Division of Laboratory Immunology, Department of Laboratory Diagnostics, University Hospital Centre Zagreb & School of Medicine, 10000 Zagreb, Croatia
- 700 1_
- $a Bourquin, Jean-Pierre $u Department of Oncology and Children's Cancer Research Center, University Children's Hospital, 8032 Zurich, Switzerland
- 700 1_
- $a Brüggemann, Monika $u Department of Hematology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany
- 700 1_
- $a Bukowska-Strakova, Karolina $u Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, 31-008 Krakow, Poland
- 700 1_
- $a Burnusuzov, Hasan $u Center of Competence "PERIMED", Department of Pediatrics, Department of Microbiology and Clinical Immunology, Medical University Plovdiv, 4002 Plovdiv, Bulgaria
- 700 1_
- $a Carelli, Daniela $u Hospital Guillermo Rawson, San Juan J5400, Argentina
- 700 1_
- $a Deniz, Günnur $u Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, 34452 Istanbul, Turkey
- 700 1_
- $a Dubravčić, Klara $u Division of Laboratory Immunology, Department of Laboratory Diagnostics, University Hospital Centre Zagreb & School of Medicine, 10000 Zagreb, Croatia
- 700 1_
- $a Feuerstein, Tamar $u The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider's Children's Medical Center, Petah Tikva 4920235, Israel
- 700 1_
- $a Gaillard, Marie Isabel $u Bioquimica, Inmunologia, Hospital de Ninos Rocardo Gutierrez, Buenos Aires C1425EFD, Argentina
- 700 1_
- $a Galeano, Adriana $u Flow Cytometry Laboratory, FUNDALEU, Buenos Aires C1114, Argentina
- 700 1_
- $a Giordano, Hugo $u Fundación Pérez Scremini, Pediatric Hematology-Oncology Service, Pereira Rossell Hospital, Montevideo 11600, Uruguay
- 700 1_
- $a Gonzalez, Alejandro $u PAPSI Laboratorio Mendoza, Rosario S2000, Argentina
- 700 1_
- $a Groeneveld-Krentz, Stefanie $u Department of Pediatric Oncology and Hematology, Charité Berlin, 10117 Berlin, Germany
- 700 1_
- $a Hevessy, Zsuzsanna $u Department of Laboratory Medicine, University of Debrecen, 4032 Debrecen, Hungary
- 700 1_
- $a Hrusak, Ondrej $u Department of Paediatric Haematology and Oncology, University Hospital Motol, 150 06 Prague, Czech Republic
- 700 1_
- $a Iarossi, Maria Belen $u Flow Cytometry Laboratory, Provincial Histocompatibility Reference Centre, CUCAIBA, Buenos Aires C1114, Argentina
- 700 1_
- $a Jáksó, Pál $u Flow Cytometry Laboratory, Department of Pathology, Clinical Centre, University of Pécs, 7622 Pécs, Hungary
- 700 1_
- $a Kloboves Prevodnik, Veronika $u Department of Cytopathology, Institute of Oncology, 1000 Ljubljana, Slovenia $u Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
- 700 1_
- $a Kohlscheen, Saskia $u Department of Hematology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany
- 700 1_
- $a Kreminska, Elena $u Clinical Laboratory Diagnostics and Metrology of NCSH "OHMATDYT", Ministry of Heath of Ukraine, 01601 Kiev, Ukraine
- 700 1_
- $a Maglia, Oscar $u M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, 20900 Monza, Italy
- 700 1_
- $a Malusardi, Cecilia $u Hospital de Clinica Jose de San Martin, Buenos Aires C1120, Argentina
- 700 1_
- $a Marinov, Neda $u PINDA, Chilean National Pediatric Oncology Group, Hospital Roberto del Rio, Universidad de Chile, Santiago 8380418, Chile
- 700 1_
- $a Martin, Bibiana Maria $u Laboratorio CEBAC SRL, Posadas N3300, Argentina
- 700 1_
- $a Möller, Claudia $u Department of Oncology and Children's Cancer Research Center, University Children's Hospital, 8032 Zurich, Switzerland
- 700 1_
- $a Nikulshin, Sergey $u Hematopathology and Flow Cytometry Division, Children's Clinical University Hospital, LV-1004 Riga, Latvia
- 700 1_
- $a Palazzi, Jorge $u IICT Labs, Rosario S2000, Argentina
- 700 1_
- $a Paterakis, Georgios $u Georgios Gennimatas General Hospital of Athens, 115 27 Athens, Greece
- 700 1_
- $a Popov, Alexander $u Laboratory of Leukemia Immunophenotyping, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997 Moscow, Russia
- 700 1_
- $a Ratei, Richard $u Clinic for Hematology and Tumor Immunology, HELIOS Klinikum Berlin-Buch, 13125 Berlin, Germany
- 700 1_
- $a Rodríguez, Cecilia $u Hospital Nacional de Clínicas, Universidad Nacional de Córdoba, Cordoba X5000HUA, Argentina
- 700 1_
- $a Sajaroff, Elisa Olga $u Cellular Immunology Laboratory, Hospital de Pediatria "Dr. Juan P. Garrahan", Buenos Aires C1245, Argentina
- 700 1_
- $a Sala, Simona $u M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, 20900 Monza, Italy
- 700 1_
- $a Samardzija, Gordana $u Laboratory for Flow Cytometry and Immunology, Institute for Health and Protection of Mother and Child of Serbia, 11070 Belgrade, Serbia
- 700 1_
- $a Sartor, Mary $u The Children's Hospital at Westmead, Sydney, NSW 2145, Australia
- 700 1_
- $a Scarparo, Pamela $u Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, University of Padova, 35122 Padova, Italy
- 700 1_
- $a Sędek, Łukasz $u Department of Microbiology and Immunology, Medical University of Silesia, 40-055 Katowice, Poland
- 700 1_
- $a Slavkovic, Bojana $u Laboratory for Flow Cytometry and Immunology, Institute for Health and Protection of Mother and Child of Serbia, 11070 Belgrade, Serbia
- 700 1_
- $a Solari, Liliana $u Servicio de Bioquimica, Hospital Posadas, Buenos Aires B1684, Argentina
- 700 1_
- $a Svec, Peter $u National Institute of Children's Diseases, 831 01 Bratislava, Slovakia
- 700 1_
- $a Szczepanski, Tomasz $u Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
- 700 1_
- $a Taparkou, Anna $u Department of Pediatric Oncology Hippokration General Hospital, 546 42 Thessaloniki, Greece
- 700 1_
- $a Torrebadell, Montserrat $u Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, 08950 Barcelona, Spain
- 700 1_
- $a Tzanoudaki, Marianna $u Department of Immunology & Histocompatibility, "Agia Sophia" Children's Hospital, 115 27 Athens, Greece
- 700 1_
- $a Varotto, Elena $u Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, University of Padova, 35122 Padova, Italy
- 700 1_
- $a Vernitsky, Helly $u Hematology Lab, Sheba Medical Center, Ramat Gan 52621, Israel
- 700 1_
- $a Attarbaschi, Andishe $u St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria
- 700 1_
- $a Schrappe, Martin $u Department of Pediatrics, University Medical Center SchleswigHolstein, Christian-Albrechts-University of Kiel, 24118 Kiel, Germany
- 700 1_
- $a Conter, Valentino $u Clinica Pediatrica University degli Studi di Milano Biococca, Fondazione MBBM, 20900 Monza, Italy
- 700 1_
- $a Biondi, Andrea $u Clinica Pediatrica University degli Studi di Milano Biococca, Fondazione MBBM, 20900 Monza, Italy
- 700 1_
- $a Felice, Marisa $u Department of Hematology and Oncology, Hospital de Pediatria "Dr. Juan P. Garrahan", Buenos Aires C1245, Argentina
- 700 1_
- $a Campbell, Myriam $u PINDA, Chilean National Pediatric Oncology Group, Hospital Roberto del Rio, Universidad de Chile, Santiago 8380418, Chile
- 700 1_
- $a Kiss, Csongor $u Division of Pediatric Hematology-Oncology, Department of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary
- 700 1_
- $a Basso, Giuseppe $u Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, University of Padova, 35122 Padova, Italy
- 700 1_
- $a Dworzak, Michael N $u Children's Cancer Research Institute, Medical University of Vienna, 1090 Vienna, Austria $u St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria
- 700 1_
- $a On Behalf Of I-Bfm-Flow-Network,
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 13, č. 23 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34885257 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220107 $b ABA008
- 991 __
- $a 20220112153458 $b ABA008
- 999 __
- $a ind $b bmc $g 1745364 $s 1152253
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 13 $c 23 $e 20211206 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- GRA __
- $a 825749 "CLOSER" $p European Union's H2020 Research and Innovation Program
- GRA __
- $a 26.01.2019 / 42/772 $p Polish Ministry of Health program
- LZP __
- $a Pubmed-20220107